Valuation : Jamjoom Pharmaceuticals Factory Company

Market Cap 9.6B 2.56B 2.2B 2.07B 1.89B 3.54B 241B 3.55B 24.47B 9.49B 124B 9.39B 399B P/E 2026 *
19.8x
P/E 2027 * 17.9x
Enterprise Value 9.29B 2.47B 2.13B 2B 1.83B 3.42B 234B 3.43B 23.66B 9.18B 120B 9.08B 386B EV / Sales 2026 *
5.65x
EV / Sales 2027 * 5.02x
Free-Float
38.61%
Yield 2026 *
3.05%
Yield 2027 * 3.45%

Last Transcript : Jamjoom Pharmaceuticals Factory Company

1 day+1.93%
1 week-1.22%
Current month+0.22%
1 month-2.90%
3 months-12.16%
6 months+3.39%
Current year-3.58%
1 week 134
Extreme 134
139.8
1 month 134
Extreme 134
143.5
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
165.3
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Director/Board Member 65 19/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%-1.22%-10.56%+17.87% 2.56B
-0.89%-1.09%+20.02%+71.25% 48.26B
-1.72%-1.15%+47.28%+115.51% 40.5B
-2.01%-5.96%+10.68%+80.50% 11.83B
-0.70%-2.70%-12.22%+11.80% 11.85B
+0.57%-0.56%+26.56%+154.33% 9.36B
-1.67%-0.35%+41.04%-12.04% 7.37B
+0.08%-4.11%+22.91%+43.56% 7.5B
-0.89%-3.09%+22.42%+220.05% 7.28B
-0.16%-2.36%-42.27%+15.39% 5.19B
Average -0.55%-2.03%+12.58%+71.82% 15.17B
Weighted average by Cap. -1.01%-1.71%+23.09%+83.19%

Financials

2026 *2027 *
Net sales 1.64B 438M 377M 354M 324M 605M 41.31B 607M 4.19B 1.62B 21.2B 1.61B 68.28B 1.83B 488M 420M 395M 361M 676M 46.1B 677M 4.67B 1.81B 23.65B 1.79B 76.2B
Net income 487M 130M 112M 105M 95.92M 179M 12.24B 180M 1.24B 481M 6.28B 476M 20.24B 536M 143M 123M 116M 106M 197M 13.48B 198M 1.37B 530M 6.91B 524M 22.28B
Net Debt -317M -84.42M -72.64M -68.35M -62.43M -117M -7.97B -117M -808M -313M -4.09B -310M -13.17B -404M -108M -92.58M -87.1M -79.57M -149M -10.16B -149M -1.03B -399M -5.21B -395M -16.79B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. pharmaceutical products represents medicines or drugs and they are essential for the prevention and treatment of diseases, and protection of public health; consumer health products represents products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
03/09/26 SAR 137.20 +1.93% 38,893
02/09/26 SAR 134.60 -1.10% 44,222
01/09/26 SAR 136.10 -0.58% 57,360
31/08/26 SAR 136.90 -1.65% 62,823
30/08/26 SAR 139.20 +0.22% 5,678
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
137.20SAR
Average target price
154.68SAR
Spread / Average Target
+12.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock